Patients with NAFLD exhibit a diminished antioxidant capacity in hepatocytes, as evidenced by a significant decrease in enzymatic antioxidants such as SOD, GPx, and catalase [44]. This evidence concerns the gene CAT and metabolic dysfunction-associated steatotic liver disease.